$7.7M Bet On This Mobile Satellite Communications Specialist? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying
Portfolio Pulse from Lisa Levin
Insiders at Remark Holdings, NeuBase Therapeutics, and Globalstar have recently made significant purchases of their companies' stocks. Remark Holdings posted a narrower Q2 loss, Symetryx Corporation acquired a 20% stake in NeuBase Therapeutics and urged a special $1 per share dividend, and Globalstar appointed a new CEO and announced a licensing agreement with XCOM Labs.
September 08, 2023 | 1:03 pm
News sentiment analysis
Sort by:
Ascending
POSITIVE IMPACT
Director James Monroe III acquired 5,080,416 shares of Globalstar at an average price of $1.52. The company appointed Paul Jacobs as CEO and announced a licensing agreement with XCOM Labs.
The insider purchase, new CEO appointment, and licensing agreement could boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 90
RELEVANCE 100
POSITIVE IMPACT
Director Theodore P Botts acquired 8,000 shares of Remark Holdings at an average price of $0.61. The company posted a narrower Q2 loss.
The insider purchase and improved Q2 results could boost investor confidence and potentially drive the stock price up in the short term.
CONFIDENCE 90
IMPORTANCE 70
RELEVANCE 100
POSITIVE IMPACT
Symetryx Corp, a 10% owner of NeuBase Therapeutics, acquired 61,076 shares at an average price of $0.98. Symetryx also acquired a 20% stake in the company and urged a special $1 per share dividend.
The insider purchase, increased stake, and potential dividend could attract more investors and potentially increase the stock price in the short term.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100